In the currently analyzed cohorts, heterozygous NTHL1 p.Q90* carriers were identified in 2.1% cases with indication of hereditary predisposition to disease and in 1.0% of the breast cancer cases unselected for family history or age at disease onset. This evidence concerns the gene NTHL1 and breast carcinoma.